# PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation

> **NCT06892457** · — · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 40 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **OTHER:** TMS-EEG

## Key facts

- **NCT ID:** NCT06892457
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-21
- **Primary completion:** 2029-10
- **Final completion:** 2029-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06892457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06892457, "PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06892457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*